Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - Forbion Capital Partners

September 10, 2015
Forbion announces the closing of FCF II Co-invest Fund I at EUR 75M
Expanding on its successful co-investment program, Forbion is pleased to announce the closing of its Forbion Capital Fund II Co-invest Fund I (FCF II Co-Invest) at EUR 75M. More

September 8, 2015
Forbion invests in Sanifit’s €36.6M ($41M) Series C financing round
Financing will advance Sanifitís lead drug candidate through the end of phase IIb as a treatment for cardiovascular diseases linked to calcification and through phase II/III for calciphylaxis.

March 24, 2015
Forbion Capital Partners Invests EUR 2.4M in 2nd Closing of Series A Financing Round for Rigontec
Forbion Capital Partners, a Dutch life-sciences venture capital firm, announces today that it has joined the 2nd closing of Rigontec's Series A financing round together with Sunstone Capital from Denmark, bringing the total capital raised in the round to EUR 14.25 Million. More

October 3, 2014
Forbion Capital Partners Announces First Close of FCF III
Forbion Capital Partners (Forbion) today announced that it has raised EUR 92m (USD 120m) in a first close of its new fund FCF III. More

February 13, 2014
Forbion Announces Closing of Initial Public Offering of Portfolio Company uniQure
From early investment to exit, uniQure exemplifies Forbion model for identifying world-leading research and active management involvement. More

January 22, 2013
Dezima Pharma in-licenses CETP Inhibitor Program from Mitsubishi Tanabe Pharma Corporation
World-renowned dyslipidemia experts join Dezimaís Scientific Advisory Board. More

November 19, 2012
Forbion Announces Appointment of Two Leading Experts as Scientific Advisors to its Various Funds
Forbion Announces Appointment of Two Leading Experts in Oncology and Metabolic Disease as Scientific Advisors to its Various Funds. More

September 10, 2012
Forbion Announces Appointment of Philip Astley-Sparke as Venture Partner
Forbion Capital Partners today announced Philip Astley-Sparke, the former President and CEO of BioVex, has joined the investment team as a venture partner based in Boston, USA. More

March 16, 2010
Forbion Capital Partners leads $12 million Series C financing of Promedior Inc.
Total Capital of $27 Million Raised by Promedior in the Past Year. More

January 5, 2010
CircuLite closes on Series C financing
Funding supports CE Mark approval and European commercialization, U.S. IDE trials, and next-generation technology development to expand Synergy commercial opportunities. More

September 10, 2009
Forbion Capital Partners co-leads EUR 9.5 million financing of arGEN-X B.V.
Company leading innovation in novel antibody-based medicines. More

August 13, 2009
Forbion Capital Partners leads $18.5 million financing of NiTi Surgical Solutions
Company leading innovation in colorectal surgery. More

March 31, 2008
Forbion’s portfolio company Transave, Inc. raises $35 million
Forbionís portfolio company Transave, Inc. raises $35 million through Series D convertible preferred stock financing More

June 7, 2007
Forbion Announces Successful Exit from Alantos Pharmaceuticals
Amgen to Acquire Alantos for $300M in cash More

May 7, 2007
Forbion Capital Partners adds top tier investors to its investor base
New investors validate the independent Forbion Team More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Mar 23€2.0MInternet services
Mar 23€1.5MInternet services
Mar 23€110.0MInternet commerce
Mar 21€1.9MBusiness applications
Mar 20€1.0MInternet commerce
Mar 20€12.0ME-Commerce

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.